_version_ 1783722163234144256
author Blazquez-Navarro, Arturo
Safi, Lema
Meister, Toni L.
Thieme, Constantin J.
Kaliszczyk, Sviatlana
Paniskaki, Krystallenia
Stockhausen, Mara
Hörstrup, Jan
Cinkilic, Okan
Flitsch-Kiefner, Linus
Marheinecke, Corinna
Steinmann, Eike
Seibert, Felix S.
Stervbo, Ulrik
Westhoff, Timm H.
Pfaender, Stephanie
Roch, Toralf
Babel, Nina
author_facet Blazquez-Navarro, Arturo
Safi, Lema
Meister, Toni L.
Thieme, Constantin J.
Kaliszczyk, Sviatlana
Paniskaki, Krystallenia
Stockhausen, Mara
Hörstrup, Jan
Cinkilic, Okan
Flitsch-Kiefner, Linus
Marheinecke, Corinna
Steinmann, Eike
Seibert, Felix S.
Stervbo, Ulrik
Westhoff, Timm H.
Pfaender, Stephanie
Roch, Toralf
Babel, Nina
author_sort Blazquez-Navarro, Arturo
collection PubMed
description
format Online
Article
Text
id pubmed-8277953
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82779532021-07-14 Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients Blazquez-Navarro, Arturo Safi, Lema Meister, Toni L. Thieme, Constantin J. Kaliszczyk, Sviatlana Paniskaki, Krystallenia Stockhausen, Mara Hörstrup, Jan Cinkilic, Okan Flitsch-Kiefner, Linus Marheinecke, Corinna Steinmann, Eike Seibert, Felix S. Stervbo, Ulrik Westhoff, Timm H. Pfaender, Stephanie Roch, Toralf Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-09 2021-07-14 /pmc/articles/PMC8277953/ /pubmed/34273381 http://dx.doi.org/10.1016/j.kint.2021.07.006 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Blazquez-Navarro, Arturo
Safi, Lema
Meister, Toni L.
Thieme, Constantin J.
Kaliszczyk, Sviatlana
Paniskaki, Krystallenia
Stockhausen, Mara
Hörstrup, Jan
Cinkilic, Okan
Flitsch-Kiefner, Linus
Marheinecke, Corinna
Steinmann, Eike
Seibert, Felix S.
Stervbo, Ulrik
Westhoff, Timm H.
Pfaender, Stephanie
Roch, Toralf
Babel, Nina
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title_full Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title_fullStr Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title_full_unstemmed Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title_short Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
title_sort superior cellular and humoral immunity toward sars-cov-2 reference and alpha and beta voc strains in covid-19 convalescent as compared to the prime boost bnt162b2-vaccinated dialysis patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277953/
https://www.ncbi.nlm.nih.gov/pubmed/34273381
http://dx.doi.org/10.1016/j.kint.2021.07.006
work_keys_str_mv AT blazqueznavarroarturo superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT safilema superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT meistertonil superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT thiemeconstantinj superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT kaliszczyksviatlana superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT paniskakikrystallenia superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT stockhausenmara superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT horstrupjan superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT cinkilicokan superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT flitschkiefnerlinus superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT marheineckecorinna superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT steinmanneike superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT seibertfelixs superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT stervboulrik superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT westhofftimmh superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT pfaenderstephanie superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT rochtoralf superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients
AT babelnina superiorcellularandhumoralimmunitytowardsarscov2referenceandalphaandbetavocstrainsincovid19convalescentascomparedtotheprimeboostbnt162b2vaccinateddialysispatients